Blue Horseshoe Stocks

Blue Horseshoe Stocks: Special Report on DKTS

Top Shelf Brands Holding Corp. DKTS

To kick things off this week, we’ve got a new interest operating in the premium spirits business, a market sector to which we have not devoted our attention in quite some time.

DKTS is a symbol that is new to our reports today as well as being fairly new overall, with just a couple months’ trading history on the books (Prior to November 2014, Top Shelf traded as TEMN). It has shown its resilience in recent sessions, but let’s take a look at what the company has going on from a business standpoint before diving into the specifics of the chart.

One particular advantage Top Shelf currently has is an active federal license to both import and supply alcoholic beverages in the US. The company’s line of products includes three offerings at the moment; a high-end tequila, a specialty liqueur, and a premium imported Champagne.

DZIAC Liqueur is a blend of vodka, pomegranate, lychee, dragonfruit, and mezcal (alcoholic beverage made from a specific strain of agave), and Arcangel is the name of Top Shelf’s variety of Champagne, which is of course imported from France.

Perhaps the most interesting is the Besado Tequila brand, which really takes traditional tequila to the next level through the addition of herbal stimulants. On top of thrice-distilled tequila made from aged blue agave, Besado contains Damiana root, which has been used for centuries in Meso-America for increased energy and sexual vigor, Maca, a vitality-inducing tuber native to the Andes Mountains, and ginseng. Two varieties will be available as pictured above.

Those three are the preliminary brands in DKTS‘s repertoire, with more expected to be added upon the successful launch of those products.

According to a recent press release, DKTS has teamed up with an experienced brand development firm to speed up the process of its beverages getting to market. Big Tent Marketing has worked on such well-known labels as Hpnotiq Liqueur, Rhythm Liqueur, Maker’s Mark Bourbon and more, and should be a good addition to DKTS’s efforts. >>> READ PR

CHART:

Getting to the DKTS Chart, we’ve got a number of ripe indicators as the price has rebounded off of a recent low of .001. The first area of resistance on the chart is sitting at .0021, and beyond that, the 200DMA (.0032). Being a stock that’s trading in the sub-penny range, we are well aware of the types of exponential gains that can be realized, and there has been some good momentum flowing through DKTS in recent sessions, so this play is high on our watchlist to start the week.

You can also take a look at the video chart we put together for DKTS this morning:

For More Info Visit:
DrinkTopShelf.com

Blue Horseshoe Stocks: BIND Recap & More

BIND Therapeutics, Inc. BIND

BIND cropped up on our premarket scanner yesterday in the wake of a post-market PR on Wednesday afternoon, and it put forth a solid move early in the session. It traded as low as 7.40 at the open, and we then witnessed a significant 36% spike to the high-of-day at 10.04.

That initial run was fueled by the release of positive Phase-2 results from one of the company’s many cancer treatments currently in various trial phases, and additionally, an update on guidance for 2015. >>> READ PR

According to the CEO, BIND expects 2015 “to be a particularly active period” with regard to the development of its many products, so this will be a play that we’ll want to monitor more closely moving forward.

Toward the end of the session yesterday BIND pulled back, and is gapping once again in the pre-market, so we have our eyes peeled for any potential bounce action that could be used in our favor.

Twitter, Inc. TWTR – Options

We’ve also got to update everyone on the options trading idea we put forth earlier this week for TWTR. We mentioned an interest in the Weekly $38 and $39 Calls, and each set of contracts showed us a huge spike during yesterday’s session.

The $38’s traded in a range from .23-1.22, for a chance at monstrous gains of up to 430%, while the $39’s did even better as they ripped from .09 to a high of .54, a move totaling 500%

We also wanted to remind readers of the long-term options idea for TWTR we mentioned in the same report. The February $40 Calls could be in line for significant gains if TWTR continues to recover off of recent lows in the $35-36 range.

Extended Watchlist:
AGEN, CERE, ARNA, SD, NVAX, CARA

Blue Horseshoe Stocks: ARNA Recap & More

Arena Pharmaceuticals, Inc. ARNA

You have to go a long way back to find our very first coverage of ARNA. It was May 11th, 2012 that we first mentioned this stock as an item to have on long-term watch. At that time the company had an obesity treatment that was awaiting FDA approval.

The public sentiment during that summer was that FDA approval was all but in the bag, and as we waited the stock began a monstrous run from a low of 5.44 to the day of its approval when it hit 13.50, an overall increase of 148% It would be a very long time before we talked about ARNA again.

The next time was fairly recently on November 3rd when we included ARNA on our Extended Watchlist, and over a period of a few sessions, saw the stock make a decent move from a low of 4.12 to 4.76. After that, it endured a series of incremental pullbacks over the next several weeks.

Yesterday morning, in a stroke of superb timing we tagged the stock in our watchlist once again, and what it did next blew the run we witnessed in November right out of the water! Coinciding with the announcement of positive top-line results on another of the company’s treatments (this one for autoimmune disease) ARNA made a huge intraday run from a low of 3.66 to all the way up to 6.09. That’s a hefty 66% increase in a single session, and it came on approximately 20X the 3-month average volume, so cheers are in order for anyone who took advantage of our timely alert!

Heritage Media Corp. HMCP

Since we mentioned HMCP for the first time on New Year’s Eve, the stock has provided us with a few quality swing-trade opportunities. That day the stock traded in a range from .0047 to .0068, an intraday gain of 45% In following sessions we then observed subsequent swings from .0037-.0064 (+73%) and .0034-.0062 (+82%) making HMCP a flipper’s dream.

As we point out on the snapshot below, what has formed on the chart is known as a bullish flag, which is known to be a signal of further gains. Couple that with an RSI that’s screaming toward the power zone, and it makes HMCP one that we’ll really need to watch closely as we head into week’s end.

Extended Watchlist:
BIND, BIOD, FOLD, NRX, CYRN, AVEO, ACUR, PLX, S

Blue Horseshoe Stocks: TWTR Options & More

Twitter, Inc. TWTR – Options Ideas

Toward the end of 2014, TWTR underwent a bit of a downturn on the heels of some insider selling and the general sluggishness of the market. The stock was beaten back into the low $35-range, and over the past couple of sessions it has done a good job of rebounding back to its highest level since the end of November. Our interest in TWTR relates specifically to the options chain, as we’ll look to take advantage of the recovery trend that’s currently in effect.

In particular the $38 (Closed @ 1.32) and $39 (Closed @ .83) Weekly Calls are catching our eye for a day-trading idea today. There is key resistance on the chart at the 50DMA 39.35, and in the premarket so far we’ve already seen trades as high as 39.60. Therefore, we’re watching for some early morning profit taking followed by a rally, where those contracts may provide some intraday trading opportunities later in the day.

For more of a long-term swing-trade idea, we can monitor the February $40 Calls (Closed @ 2.70).

Frontline Ltd. FRO

FRO made a nice move for us after appearing in yesterday morning’s report; the stock traded in a daily range from 2.83 to 3.27 (+15%), and did so on healthy volume to the tune of roughly 9X the 3-month average. We continue to watch FRO this morning as it gaps up in the premarket, with trades already having gone off as high as 3.61, which represents an overall increase of 28% over yesterday’s observed low.

As noted in an article on The Street, some bullish comments made about FRO on CNBC yesterday could be partly responsible for the strong session.

Extended Watchlist:
JCP, GALT, ARNA, PKT, NLST

Blue Horseshoe Stocks: NQ Review & More

NQ Mobile, Inc. NQ

Our coverage of NQ stretches all the way back to the Fall of 2013 when the stock made a huge run, and we tracked it to a similar albeit smaller-scale spike in October, so we are quite familiar with this play. We have good reason to re-assess NQ this morning in the wake of an interesting PR, coupled with a good positioning of the chart.

In terms of the NQ chart, there a couple of finer points that we’ll point out on the following snapshot:

This morning’s PR relates to a big open market stock repurchase by management which seems to be fueling NQ in the premarket. >>> VIEW PR

Cannabis Coverage:

A few of the marijuana-related stocks we were mentioning yesterday morning managed to put up some solid numbers over the course of the day.

CBIS traded in a range from .068-.08 (+17%) on roughly 4X its monthly average volume.

MCIG did slightly better as recorded a 19% move from .15 to .178, trading more than twice its average volume.

EAPH also had a heavy volume day to the tune of roughly 3X its average, and made a healthy jump of 21% as it traded from its open at .024 to a high of .029.

As medical and recreational marijuana acceptance continues to spread, we’ll need to keep a close eye on these and many other cannabis plays, as we tend to believe that growth in this arena will be more substantial in 2015 than any previous year.

A few other pot plays to watch this week: WDHR, NRTI, MDCN, LATF, VPOR

Extended Watchlist:
CYTR, NERV, FRO, CPST, DARA, MNK, SNSS, RNN